Autolus Therapeutics Stock Performance
as on August 22, 2026 at 2:15 pm IST
Day's Low
Day's High
$2.40$2.51
0.41%
Downside
4.15%
Upside
52 Week's Low
52 Week's High
$1.18$2.4351.24%
Downside
0.83%
Upside
Autolus Therapeutics share price movements today
- Previous Close
- $2.46
- Open
- $2.47
- Volume
- 2.9M
- Market Cap
- $572.2M
- Day's Low - High
- $2.40 - $2.51
- 52 Week Low - High
- $1.18 - $2.43
Autolus Therapeutics Historical Returns
- 1 Month Return
- + 49.31 %
- 3 Month Return
- + 31.9 %
- 1 Year Return
- + 20.79 %
- 3 Year Return
- -26.87 %
- 5 Year Return
- -62.61 %
Autolus Therapeutics Stock Fundamentals & Key Indicators
Check Autolus Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$572.2M
EPS (TTM)
-1.06
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.09
Industry PE ratio
-7.283372093023256
PEG Ratio
0.07924215810359019
EBITDA
-221.4M
Revenue (TTM)
117.4M
Profit Margin
15.66%
Return On Equity TTM
-178.58%
Autolus Therapeutics Stock Valuation
Track how Autolus Therapeutics P/E has moved over time to understand its valuation trends.
Autolus Therapeutics in the last 5 years
Lowest (-5.38x)
December 31, 2023
Industry (-7.28x)
December 31, 2025
Today (-1.84x)
December 31, 2025
Highest (-1.21x)
December 31, 2022
Today’s Price to Earnings Ratio: -1.84x
Autolus Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Autolus Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $572.2M | -62.61% | -2.09 | 15.66% | NA | |
| BUY | $43.7B | 669.3% | NA | 0.00% | NA | |
| BUY | $128.2B | 154.86% | 29.82 | 86.04% | NA | |
| BUY | $25.3B | -84.24% | -7.98 | -12.57% | NA | |
| BUY | $82.7B | 24.1% | 19.24 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Autolus Therapeutics Stock including INR - Dollar returns
The Autolus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Autolus Therapeutics investment value today
Current value as on today
₹1,48,384
Returns
₹48,384
(+48.38%)
Returns from Autolus Therapeutics Stock
₹35,393 (+35.39%)
Dollar Impact
₹12,990 (+12.99%)
Analyst Recommendation on Autolus Therapeutics Stock
Based on 6 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Autolus Therapeutics. Average target price of $8.72
Autolus Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Autolus Therapeutics.
What analysts predicted
72.36%UPSIDE
Target Price
$8.72
Current Price
$2.41
Analyzed by
6 Analysts
Target
$8.72
Autolus Therapeutics target price $8.72, a slight upside of 72.36% compared to current price of $2.41. According to 6 analysts rating.
Indian Investors' Interest in Autolus Therapeutics Stock
Search interest for Autolus Therapeutics Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:133% versus previous 30 day period
Autolus Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Autolus Therapeutics Annual Profit & Loss
All numbers in Millions USD
Autolus Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Autolus Therapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Autolus Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, AUTL stock has moved up by 12.1%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 7 quarters, 29.0K → 45.68M (in $), with an average increase of 36.8% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -90.20M → -39.11M (in $), with an average increase of 54.5% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 428.3%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 586.8% return, outperforming this stock by 613.1%
About Autolus Therapeutics
| Organisation | Autolus Therapeutics |
| Headquarters | The Mediaworks, London, United Kingdom, W12 7FP |
| Industry | Biotechnology |
| CEO | Dr. Christian Martin Itin Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Autolus Therapeutics
Name | Title |
|---|---|
Mr. Robert F. Dolski | Senior VP & CFO |
Mr. Christopher Vann | Senior VP & COO |
Mr. Alex Driggs | Senior VP of Legal Affairs & General Counsel and Secretary |
Mr. Alexander Swan | Senior VP & Chief Human Resources Officer |
Dr. Matthias Will M.D. | Senior VP & Chief Development Officer |
Dr. Christian Martin Itin Ph.D. | CEO & Director |
Dr. Martin Pule M.D., MBBS | Founder, Senior VP & Chief Scientific Officer |
Mr. Patrick McIlvenny | Senior VP of Finance, Chief Accounting Officer & Principal Accounting Officer |
Ms. Miranda Neville | Senior VP & Chief Technology Officer |
Dr. Christopher Williams Ph.D. | Senior VP & Chief Business Development Officer |
FAQs
What is Autolus Therapeutics share price today?
Autolus Therapeutics share price today is $2.41 as on at the close of the market. Autolus Therapeutics share today touched a day high of $2.51 and a low of $2.40.
What is the 52 week high and 52 week low for Autolus Therapeutics share?
Autolus Therapeutics share touched a 52 week high of $2.43 on and a 52 week low of $1.18 on . Autolus Therapeutics stock price today i.e. is closed at $2.41,which is 0.82% down from its 52 week high and 105.11% up from its 52 week low.
What is Autolus Therapeutics's market capitalisation today?
Autolus Therapeutics market capitalisation is $0.00T as on .
How to invest in Autolus Therapeutics Stock (AUTL) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Autolus Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Autolus Therapeutics Shares that will get you 0.6224 shares as per Autolus Therapeutics share price of $2.41 per share as on August 22, 2026 at 8:45 am IST.
What is the minimum amount required to buy Autolus Therapeutics Stock (AUTL) from India?
Indian investors can start investing in Autolus Therapeutics (AUTL) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in Autolus Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Autolus Therapeutics share’s latest price of $2.41 as on August 22, 2026 at 8:45 am IST, you will get 4.1494 shares of Autolus Therapeutics. Learn more about
fractional shares .
What are the returns that Autolus Therapeutics has given to Indian investors in the last 5 years?
Autolus Therapeutics stock has given -62.61% share price returns and 29.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?